Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Breye Therapeutics ApS
APS
Active
Advertising protection
CVR 40279865
Agern Alle 24, 2970
Hørsholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 7 years old
4 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Breye Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
-1M
2022
-3M
2023
-8M
2024
-8M
2025
EBITDA
DKK millions
0M
-26M
-51M
-77M
-103M
0M
2021
-1M
-100%
2022
-20M
-1900%
2023
-75M
-275%
2024
-82M
-9%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-68
-674
-2.883
-7.812
-7.546
Staff expenses
-247
-64
-1.717
-6.407
-7.080
EBITDA
-315
-738
-19.836
-74.961
-82.242
Depreciation & amort.
-0
-0
-0
-411
-397
EBIT
-315
-738
-19.836
-75.372
-82.639
Net financials
-28
-42
-941
-273
-12.001
Profit before tax
-342
-780
-20.777
-75.646
-94.640
Tax
-53
-0
-6.202
-5.496
-5.500
Net profit
-290
-780
-14.575
-70.150
-89.140
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
14.174
18.746
24.815
60.682
57.048
Equity
28
-752
14.526
48.485
-40.638
Long-term debt
13.814
18.478
7.101
3.767
1.944
Short-term debt
332
1.020
3.188
8.430
95.741
Total debt
14.146
19.498
10.289
12.196
97.685
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-8224220000.0%
This company
2021
2025
Equity ratio
-71.2%
This company
38.2%
Market median
-286% vs market
2021
2025
Return on equity
-8913984600.0%
This company
18.4%
Market median
-48445568578% vs market
2021
2025
Net profit margin (of gross profit)
-8913984600.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.13×
This company
2021
2025
Debt / equity
2.40×
This company
0.62×
Market median
-287% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
More on Breye Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
